Company profile
Sichuan Dingke Pharmaceutical Co., Ltd. was established in Sep. 2022 and is a high-tech enterprise majority-owned by Chongqing Xieran Pharma.
Dingke Pharmaceutical has advanced production equipment, excellent production technology, mature production process and strict quality control, and has excellent independent R&D capabilities.
Guided by our core values of dedication, resilience, innovation, and shared success, we are deeply focused on advancing the field of APIs and specialized fine chemicals. Our mission is to become a leading supplier of specialty APIs in Southwest China and a benchmark enterprise in the fields of orthopedics, dermatology, and neuropsychiatric medications across the domestic market.
Our manufacturing facility is located in the Yuechi County Pharmaceutical Industrial Park in Guang’an City, Sichuan Province. The site spans approximately 148,666 square meters, with a total planned investment of around USD 420 million. The project follows a phased construction strategy aligned with a comprehensive development plan, with full completion expected within five years.
Once fully operational, the facility will house 11 production workshops for APIs and intermediates, along with one integrated formulation workshop. The site is designed to achieve an annual production capacity of over 5,000 metric tons of APIs and pharmaceutical intermediates. Phase I of the project is scheduled to be completed and enter operation by August 2025, with commercial production and sales targeted by the end of the year.